본문 바로가기
KERD
논문KCI 등재

쥐 비만세포 (RBL-2H3)와 OVA/alum 감작 마우스에서 치자 추출물의 알레르기 염증 억제 효과

The Effects of Gardenia jasminoides J.Ellis on Allergic Inflammation in RBL-2H3 Mast Cells and OVA/alum-sensitized Mice

1

조회

0

다운로드

2

인용

0

참고문헌

키워드

주제분류한의학

초록

Objectives The purpose of this study is to investigate the effects of Gardenia jasminoides for. grandiflora extracts’ (GAJ) anti-inflammatory effect on RBL-2H3 mast cells and OVA/alum-sensitized mice. Methods In this study, IL-4 and IL-13 production was measured via ELISA analysis, and mRNA expressions of GM-CSF, IL-4, IL-5, TNF-α, IL-6 were analyzed by real-time PCR. In addition, MAPKs and NF-κB p65 transcription factors were examined using western blotting, and ELISA was used to understand IgE, IL-4, and IL-13 production in ovalbumin-allergic mice in in vitro study. Results As a result of this study, 1. GAJ were observed to suppress the mRNA expression of GM-CSF, IL-4, IL-13, IL-5, TNF-α, IL-6 in comparison to PMA 50 ng/㎖, ionomycin 0.5 μM (PI) control group. 2. GAJ also inhibited the IL-4, IL-13 production in comparison to PI control group. 3. Western blot analysis showed decrease on the expression of mast-cell-specific transcription factors, including MAKPs (ERK, JNK, p38) and NF-κB p65. 4. Orally-administered GAJ group in OVA/alum induced Balb/c mice showed decreased level of OVA-specific IgE in the serum. This group also has shown decreased the level of IL-4, IL-13 in the splenocyte culture supernatant. Conclusions Obtained results suggest that GAJ may regulate the allergic inflammation by transcription factors MAKPs (ERK, JNK, p38) and NF-κB p65 causing inhibition of Th2 cytokines in mast cells and OVA/alum-sensitized mice.

Abstract

Objectives The purpose of this study is to investigate the effects of Gardenia jasminoides for. grandiflora extracts’ (GAJ) anti-inflammatory effect on RBL-2H3 mast cells and OVA/alum-sensitized mice. Methods In this study, IL-4 and IL-13 production was measured via ELISA analysis, and mRNA expressions of GM-CSF, IL-4, IL-5, TNF-α, IL-6 were analyzed by real-time PCR. In addition, MAPKs and NF-κB p65 transcription factors were examined using western blotting, and ELISA was used to understand IgE, IL-4, and IL-13 production in ovalbumin-allergic mice in in vitro study. Results As a result of this study, 1. GAJ were observed to suppress the mRNA expression of GM-CSF, IL-4, IL-13, IL-5, TNF-α, IL-6 in comparison to PMA 50 ng/㎖, ionomycin 0.5 μM (PI) control group. 2. GAJ also inhibited the IL-4, IL-13 production in comparison to PI control group. 3. Western blot analysis showed decrease on the expression of mast-cell-specific transcription factors, including MAKPs (ERK, JNK, p38) and NF-κB p65. 4. Orally-administered GAJ group in OVA/alum induced Balb/c mice showed decreased level of OVA-specific IgE in the serum. This group also has shown decreased the level of IL-4, IL-13 in the splenocyte culture supernatant. Conclusions Obtained results suggest that GAJ may regulate the allergic inflammation by transcription factors MAKPs (ERK, JNK, p38) and NF-κB p65 causing inhibition of Th2 cytokines in mast cells and OVA/alum-sensitized mice.

참고문헌 (47)

  1. Korean Medicine University Herbal Medicine Commission, "Herbal medicine", pp.208~209 (2008), Yeongrim Publishing Co
  2. Debnath T, "Antioxidant activity of Gardenia jasminoides Ellis fruit extracts", Food Chem, 128(3), pp.697~703 (2011)
  3. Lin YJ, "Inhibition of enterovirus 71infections and viral IRES activity by Fructus gardeniae and geniposide", Eur J Med Chem, 62, pp.206~213 (2013)
  4. Toriizuka K, "Anxiolytic effect of Gardeniae Fructus-extract containing active ingredient from Kamishoyosan(KSS), a Japanese traditional Kampo medicine", Life Sci, 77(24), pp.3010~3020 (2005)
  5. 민동훈, "화상 및 창상에 대한 자근·치자 복합제제의 경피 흡수 및 치료효과", Journal of Pharmaceutical Investigation, 35(4), pp.255~263 (2005), 한국약제학회
  6. 양재헌, "치자 엑스의 가수분해에 의한 피부투과 및 항염효과", Journal of Pharmaceutical Investigation, 34(2), pp.115~123 (2004), 한국약제학회
  7. An HS, "Textbook of pediatrics", pp.1104~1121 (2010), Korea Textbook Publishing Co
  8. 강기연, "MC", 9 비만세포에서 杏仁 추출물의 Th2 cytokine 발현 억제 효과 및 신호전달 기전 연구, 2014, pp.28(2), 23~39[DOI]
  9. Park Y, "Moisturizers in atopic dermatitis", J Skin Barrier Res(Korean), 9(1), pp.37~40 (2007)
  10. Abbas AK, "Cellular & molecular immunology", pp.451~471 (2008), Epublic Publishing Co
  11. Kim JW, "Atopic dermatitis at allergic and immunological aspects", J Korean Dermatol Assoc, 41(6), pp.687~689 (2003)
  12. Renz H, "Enhanced IL-4 production and IL-4receptor expression in atopic dermatitis and their modulation by interferon-gamma", J Invest Dermatol, 99(4), pp.403~408 (1992)
  13. 차지혜, "梔子가 대식세포의 Cytokine에 미치는 영향", 대한한방부인과학회지, 27(1), pp.1~16 (2014), 대한한방부인과학회[DOI]
  14. Sea S., "Research for the effect of Gardeniae Fructus on regulatory T cell stimulation", Master, pp.2010
  15. Ishiyama M, "A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability", Talanta, 44(7), pp.1299~1305 (1997)
  16. Leung DY, "Deciphering the complexities of atopic dermatitis : shifting paradigms in treatment approaches", J Allergy Clin Immunol, 134(4), pp.769~779 (2014)
  17. Cork MJ, "Epidermal barrier dysfunction in atopic dermatitis", J Invest Dermatol, 129(8), pp.1892~1908 (2009)
  18. "Environment day right environment -related diseases health insurance representative 3 payment data analysis"[URL]
  19. 장호선, "아토피 피부염의 진단과 치료", Korean Journal of Family Medicine, 23(7), pp.2~840 (2002), 대한가정의학회
  20. Korea Centers for Disease Control and Prevent, "The use of alternative medicine and management in children with atopic dermatitis", Korean J Pediatr, 18(2), pp.148~157 (2008)
  21. 진현우, "아토피피부염 환자의 대체의학 이용 실태에 관한 연구", 대한피부과학회지, 43(7), pp.903~911 (2005), 대한피부과학회
  22. 김세희, "소아 아토피피부염에서 한의학 및 보완대체의학의 이용", 석사, 대체의학, pp.2007
  23. 고덕재, "Clinical Assessment of Efficacy, Safety and Usefulness of Traditional Herbal Medicine (THM) on Atopic Dermatitis", 대한한방소아과학회지, 20(2), pp.129~137 (2006), 대한한방소아과학회
  24. Kang TJ, "Causes and treatment management of atopic dermatitis", BioWave, 12(3), pp.1~25 (2010)
  25. Izuhara K, "Emerging therapeutic targets in allergic disease", Pharmacol Ther, 25(3), pp.381~389 (2005)
  26. Gibbs BF, "Early IgE-dependent release of IL-4 and IL-13 from leukocytes is restricted to basophils: a comparison with other granulocytes and mononuclear cells", Inflamm Res, 49(Suppl1), pp.S9~S10 (2000)
  27. Valent P, "Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor", kit-ligand in long-term culture, 1992, pp.80(9), 2237~2245
  28. Kim HC, "Korean medicine pharmacology", pp.125~127 (2001), Jibmun Publishing Co
  29. Lee CB, "Coloured flora of Korea" (2003), Hyangmunsa
  30. Alavizadeh SH, "Bioactivity assessment and toxicity of crocin : a comprehensive review", Food Chem Toxicol, 64, pp.65~80 (2014)
  31. 신용욱, "한약의 수치에 관한 연구(제 7보) - 치자의 수치에 의한 성분변화 및 생리활성 -", 생약학회지, 34(1), pp.45~54 (2003), 한국생약학회
  32. Kim HJ, "Vanillic acid glycoside and quinic acid derivatives from Gardeniae Fructus", J Nat Prod, 69(4), pp.600~603 (2006)
  33. 천승철, "內疎黃連湯 및 구성약물의 항균활성에 관한 실험적 연구", 대한본초학회지, 19(4), pp.51~60 (2004), 대한본초학회
  34. Choi CS, "Antibacterial activity of soluble extracts of Gardenia jasminoides against mycobacteria other than Tubercle Bacilli", J Korea Soc Microbiol, 21(1), pp.53~62 (1986)
  35. 김미정, "케토롤락과 치자엑스 가수분해물 제제의 랫트에 대한 항염 및 진통완화효과", 대한구강보건학회지, 28(4), pp.464~472 (2004), 대한예방치과·구강보건학회
  36. Han YN, "Antioxidant components of Gardenia Fruit", Kor J Pharmacogn, 25(3), pp.226~232 (1994)
  37. 황금희, "치자추출물의 Monoamine Oxidase 저해활성", 생약학회지, 38(2), pp.108~112 (2007), 한국생약학회
  38. Koo HJ, "Anti-inflammatory evaluation of gardenia extract, geniposide and genipin", J Ethnopharmacol, 103(3), pp.496~500 (2006)
  39. Wang GF, "Genipin inhibits endothelial exocytosis via nitric oxide in cultured human umbilical vein endothelial cells", Acta Pharmacol Sin, 30(5), pp.589~596 (2009)
  40. Prieschl EE, "A nuclear factor of activated T cell-like transcription factor in mast cells is involved in IL-5gene regulation after IgE plus antigen stimulation", J Immunol, 154(11), pp.6112~6119 (1995)
  41. Aversa G, "An interleukin 4(IL-4)mutant protein inhibits both IL-4 or IL-13-induced human immunoglobulin G4(IgG4)and IgE synthesis and B cell proliferation : support for a common component shared by IL-4 and IL-13 receptors", J Exp Med, 178(6), pp.2213~2218 (1993)
  42. 이임선, "NFAT(nuclear factor of activated T cells) 전사인자에 대한 천연물의 저해활성", 생약학회지, 34(2), pp.150~155 (2003), 한국생약학회
  43. Liebmann C, "Regulation of MAP kinase activity by peptide receptor signalling pathway : paradigms of multiplicity", Cell Signal, 13(11), pp.777~785 (2001)
  44. Cheung PF, "Activation of human eosinophils and epidermal keratinocytes by Th2 cytokine IL-31 : implication for the immunopathogenesis of atopic dermatitis", Int Immunol, 22(6), pp.453~467 (2010)
  45. Park GY, "Pro-inflammatory cytokine expression through NF-κB", IκB pathway in lung epithelial cells, 2000, pp.49(3), 332~342
  46. Pahl HL, "Activators and target genes of Rel", NF-kappaB transcription factors, 1999, pp.18(49), 6853~6866
  47. Abul K. Abbas, "Basic Immunology", pp.104~111 (2009), Epublic Publishing Co

이 간행물의 다른 논문 (11건)